Novartis Ag (NVS) Payout Ratio (2009 - 2026)
Novartis Ag's (NVS) quarterly Payout Ratio came in at 0.88 in Q2 2026, down 43.04% year-over-year from 1.54 in Q2 2025, and up 35.82% quarter-over-quarter from 1.37 in Q1 2026.
Analysis
Novartis Ag (NVS) Payout Ratio (2009 - 2026) Analysis & Trends
Novartis Ag has disclosed Payout Ratio across 18 years of filings, most recently posting 0.88 for Q2 2026.
- In Q2 2026, Payout Ratio fell 43.04% year-over-year to 0.88; the TTM figure through Jun 2026 stood at 0.75 (down 18.74% YoY), while the FY2025 annual figure was 0.56, up 12.44% from the prior year.
- Payout Ratio came in at 0.88 for Q2 2026 at Novartis Ag, up from 1.37 in the prior quarter.
- In the past five years, Payout Ratio ranged from a high of 0.61 in Q2 2025 to a low of 2.41 in Q1 2022.
- Average Payout Ratio over 5 years is 1.23, with a median of 0.95 recorded in 2025.
- Year-over-year, Payout Ratio soared 39.0% in 2024 and slumped 43.04% in 2026.
- Over 5 years, Payout Ratio stood at 2.41 in 2022, then gained by 0.64% to 2.39 in 2023, then soared by 72.49% to 0.66 in 2024, then decreased by 16.04% to 0.76 in 2025, then declined by 15.24% to 0.88 in 2026.
- Per Business Quant data, the three most recent Payout Ratio figures were 0.88 in Q2 2026, 1.37 in Q1 2026, and 0.76 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 648.10 Bn | 627.34 Bn | 17.26 Bn |
| 2 | AbbVie | 441.84 Bn | 435.27 Bn | 12.70 Bn |
| 3 | Merck | 364.97 Bn | 357.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 267.08 Bn | 259.39 Bn | 11.24 Bn |
| 5 | Pfizer | 158.83 Bn | 147.13 Bn | 10.94 Bn |
| 6 | Sanofi | 52.56 Bn | 45.18 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 44.29 Bn | 44.29 Bn | - |
| 8 | Incyte | 25.35 Bn | 20.81 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.31 Bn | 18.65 Bn | 683.80 Mn |
| 10 | Neurocrine Biosciences | 15.54 Bn | 15.15 Bn | 935.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.88 |
| Mar 31, 2026 | -1.37 |
| Dec 31, 2025 | -0.76 |
| Jun 30, 2025 | -0.61 |
| Mar 31, 2025 | -1.02 |
| Dec 31, 2024 | -0.66 |
| Jun 30, 2024 | -0.74 |
| Mar 31, 2024 | -1.46 |
| Mar 31, 2023 | -2.39 |
| Mar 31, 2022 | -2.41 |
| Mar 31, 2021 | -2.59 |
| Dec 31, 2020 | 1.19 |
| Mar 31, 2020 | -2.28 |
| Dec 31, 2019 | -0.53 |
| Mar 31, 2019 | -2.28 |
| Mar 31, 2018 | -2.56 |
| Mar 31, 2017 | -2.91 |
| Dec 31, 2016 | -1.27 |
| Mar 31, 2016 | -2.40 |
| Dec 31, 2015 | -1.21 |